Bambusa Therapeutics

Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on

Aspen Neuroscience and Bambusa Therapeutics launched US IPO roadshows, adding to a biotech sector wave despite rising borrowing costs. Both firms are developing early-stage therapies for neurodegenera